Company Size
11 - 50 employees
Year Founded
2021
About Next Sequence
We help founders build the most disruptive companies at the edge of Synthetic Biology and A.I. or Quantum Computing.
Our mission is to contribute to the development of the most disruptive companies that want to enable humanity to face up to its next challenges as a species from fighting genetically transmitted diseases and pandemics to preventing ageing and climate change.
Financials Beta
Business Model: Not Specified
Revenues: Not Specified
Expenses: Not Specified
Debt: Request
Operating Status: Active
Funding Raised: $0
Investment Rounds: 0 Rounds
Funding Stage: Not Specified
Last Funding Date: Not Specified
